Previous 10 | Next 10 |
State-of-the-Art Facility to Offer Access to Psilocybin Treatments FT. LAUDERDALE, FL / ACCESSWIRE / September 28, 2023 / Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS) announced today that it has secured premium space for its planned psilocybin treatment center, The Sacred Mush...
FT. LAUDERDALE, FL / ACCESSWIRE / February 15, 2023 / Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS), a pioneer in the U.S. cannabis industry, announced today that its subsidiary Fifth Dimension Therapeutics™ (FDT) has reached an agreement in principle with Florida-based Tota...
Global Psychedelic Therapeutics Market Expected to Reach $8-10 Billion by 2028. FT. LAUDERDALE, FL / ACCESSWIRE / August 3, 2022 / Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS) , the first U.S. publicly traded company to hold and operate cannabis licenses in all "touch th...
Kaya ( OTCQB:KAYS ) stock gained 15.4% on Wednesday after the firm's unit Kaya Farms Greece's joint venture project - Greek Kaya - received cannabis installation license . The license allows for the development of a planned medical cannabis facility in Epidaurus, Greece. ...
FT. LAUDERDALE, FL / ACCESSWIRE / July 6, 2022 / Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS) , the first U.S. publ6cly traded company to hold and operate cannabis licenses in all "touch the plant" categories, announced today that its majority owned subsidiary Kaya Farms Gree...
The Epidaurus, Greece EU-GMP Cannabis Cultivation and Manufacturing Facility is expected to open the EU Market to KAYS' branded cannabis products. FT. LAUDERDALE, FL / ACCESSWIRE / January 11, 2022 / Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS), the first U.S. publicly tr...
FT. LAUDERDALE, Fl / ACCESSWIRE / October 26, 2021 / Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB.KAYS), the first U.S. publicly traded company to engage in touch-the-plant cannabis activities, announced today that it has completed the sale of its Eugene, Oregon cannabis facility fo...
Proceeds of Sale to be Used to Advance U.S. and Overseas Projects and Strengthen Balance Sheet FT. LAUDERDALE, FL / ACCESSWIRE / July 28, 2021 / Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS), the first U.S. publicly traded company to hold and operate state-issued "touch-th...
A limited number of seats are still available; click on the link in the article below to attend. FT. LAUDERDALE, FL / ACCESSWIRE / May 20, 2021 / Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS): "Cannabis Investment: How Greece is Embracing the Opportunity and Leading ...
FT. LAUDERDALE, FL / ACCESSWIRE / May 18, 2021 / Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS), announced today that it will be participating in a webinar co-sponsored by the international law firm Duane Morris on Cannabis in Greece on Thursday, May 20, 2021 at 12:30 pm. "C...
News, Short Squeeze, Breakout and More Instantly...
KAYS CEO Craig Frank to receive The Sacred Mushroom's first Psilocybin Treatment FT. LAUDERDALE, FL / ACCESSWIRE / July 2, 2024 / Kaya Holdings, Inc. ("KAYS" or the "Company") (OTCQB:KAYS), announced today that its licensed psilocybin treatment center in Portland, Oregon, The Sacred Mushroom...
FT. LAUDERDALE, FL / ACCESSWIRE / June 5, 2024 / Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS) announced today that its majority owned subsidiary, Fifth Dimension Therapeutics, Inc. has begun accepting appointments at its The Sacred Mushroom™ ("TSM") Psilocybin Treatment cen...
FT. LAUDERDALE, FL / ACCESSWIRE / May 7, 2024 / Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS) announced today that the Company has been awarded its license to operate a Psilocybin Service Center by the Oregon Health Authority (the "OHA"). ...